![Lars HOLTEN-ANDERSEN | Director of Preclinical Development | Ascendis Pharma, Gentofte | Nonclinical Development | profile on ResearchGate Lars HOLTEN-ANDERSEN | Director of Preclinical Development | Ascendis Pharma, Gentofte | Nonclinical Development | profile on ResearchGate](https://i1.rgstatic.net/ii/profile.image/410519891660803-1474886977668_Q512/Lars-Holten-Andersen.jpg)
Lars HOLTEN-ANDERSEN | Director of Preclinical Development | Ascendis Pharma, Gentofte | Nonclinical Development | profile on ResearchGate
Liver Volume, Portal Vein Flow, and Clearance of Indocyanine Green and Antipyrine in Hyperthyroidism before and after Antithyroi
![Mette ANDERSEN | PhD Student | Copenhagen University Hospital Gentofte, Gentofte | Department of Cardiology Mette ANDERSEN | PhD Student | Copenhagen University Hospital Gentofte, Gentofte | Department of Cardiology](https://i1.rgstatic.net/ii/profile.image/281155787083776-1444044171297_Q512/Mette-Andersen-8.jpg)
Mette ANDERSEN | PhD Student | Copenhagen University Hospital Gentofte, Gentofte | Department of Cardiology
![PDF) Targeting “hardly reached” people with chronic illness: A feasibility study of a person-centered self-management education approach PDF) Targeting “hardly reached” people with chronic illness: A feasibility study of a person-centered self-management education approach](https://i1.rgstatic.net/publication/323198298_Targeting_hardly_reached_people_with_chronic_illness_A_feasibility_study_of_a_person-centered_self-management_education_approach/links/5a8584cf0f7e9b2c3f53127f/largepreview.png)